In the case of BC, population-based studies of common CYP19A1 polymorphisms have generated inconsistent results with regard to their possible association with sex hormone levels, cancer risk, HER2 status or survival [15,19,21,27,28]. The gene discussed is CYP19A1; the disease is cancer.